^○Sri Wahyuni ANAK AYU¹, Raka Sudewi A. A.⁴, Mahardika I. G. N.², Rustika MADE³ (1. Faculty of Medicine, Department of Psychiatry, Udayana University , 2. Faculty of Veterinary Medicine, Department of Veterinary Medicine, Udayana University, 3. Faculty of Medicine, Department of Behavioural Sciences, Udayana University, 4. Faculty of Medicine, Department of Neurology, Udayana University )

^○Eri SEGI-NISHIDA, Sara NANNO, Taiga AKUHARA, Risa HYODO, Akari NISHIYAMA (Department of Biological Science and Technology, Tokyo University of Science, Tokyo Japan)

^○Yukiori GOTO⁴, Shino OGAWA¹, Mayuko IRIGUCHI², Young-A LEE³, Sakiko YOSHIKAWA¹ (1. Kokoro Research Center, Kyoto University, Kyoto, Japan, 2. Department of Neurobiology and Behavior, Nagasaki University, Nagasaki, Japan, 3. Department of Food Sciences and Nutrition, Daegu Catholic University, Gyeongsan, South Korea, 4. Primate Research Institute, Kyoto University, Inuyama, Japan)

^○Soyeon PARK, Kikyung LEE, Hyejin SEO (Department of Psychiatry, Yongin mental hospital)

^○Toshihiro ENDO^{1, 2}, Seico BENNER³, Hidenori YAMASUE³, Hans-Peter LIPP⁴ (1. Phenovance Research and Technology LLC, Chiba, Japan, 2. Faculty of Medicine, University of Tsukuba, Ibaraki, Japan, 3. Department of Psychiatry, Hamamatsu University School of Medicine, Shizuoka, Japan, 4. Neurospex GmbH, Switzerland)

^○Toshihiro ENDO^{1, 2}, Hidenori NAKAMURA³ (1. Phenovance Research and Technology LLC, Chiba, Japan, 2. Faculty of Medicine, University of Tsukuba, Ibaraki, Japan, 3. atDose Co., Ltd., Kanagawa, Japan)

^○Toshihiro ENDO^{1, 2}, Seico BENNER³, Hans-Peter LIPP⁴, Chiharu TOHYAMA² (1. Phenovance Research and Technology LLC, Chiba, Japan, 2. Faculty of Medicine, University of Tsukuba, Ibaraki, Japan, 3. Department of Psychiatry, Hamamatsu University School of Medicine, Shizuoka, Japan, 4. Neurospex GmbH, Switzerland)